5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole

C106H110N20O10 — CID 158003016

IUPAC5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole
SMILESCC(C)(C)c1cc(-c2nc(-c3ccncc3)no2)cc(C(C)(C)C)c1.CC(C)Cc1ccc(C(C)c2nc(-c3ccncc3)no2)cc1.CCOc1ccc(-c2nc(-c3ccncc3)no2)c(O)c1.CCn1nc(C)cc1-c1nc(-c2ccncc2)no1.COc1ccc(-c2nc(-c3ccncc3)no2)cc1OC1CCCC1.c1cc(-c2noc(-c3ccc(C4CCCCC4)cc3)n2)ccn1
InChIInChI=1S/C21H25N3O.C19H19N3O3.C19H19N3O.C19H21N3O.C15H13N3O3.C13H13N5O/c1-20(2,3)16-11-15(12-17(13-16)21(4,5)6)19-23-18(24-25-19)14-7-9-22-10-8-14;1-23-16-7-6-14(12-17(16)24-15-4-2-3-5-15)19-21-18(22-25-19)13-8-10-20-11-9-13;1-2-4-14(5-3-1)15-6-8-17(9-7-15)19-21-18(22-23-19)16-10-12-20-13-11-16;1-13(2)12-15-4-6-16(7-5-15)14(3)19-21-18(22-23-19)17-8-10-20-11-9-17;1-2-20-11-3-4-12(13(19)9-11)15-17-14(18-21-15)10-5-7-16-8-6-10;1-3-18-11(8-9(2)16-18)13-15-12(17-19-13)10-4-6-14-7-5-10/h7-13H,1-6H3;6-12,15H,2-5H2,1H3;6-14H,1-5H2;4-11,13-14H,12H2,1-3H3;3-9,19H,2H2,1H3;4-8H,3H2,1-2H3
InChIKeyFDYOGOCTEIJWFC-UHFFFAOYSA-N
MW1824.18 g/mol
LogP24.08
Rot. Bonds22

About 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole

5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole (PubChem CID 158003016) has the molecular formula C106H110N20O10 and a molecular weight of 1824.18 g/mol. Its IUPAC name is 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole
PubChem CID158003016
Molecular FormulaC106H110N20O10
Molecular Weight1824.18 g/mol
Exact Mass1822.87
IUPAC Name5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole
SMILESCC(C)(C)c1cc(-c2nc(-c3ccncc3)no2)cc(C(C)(C)C)c1.CC(C)Cc1ccc(C(C)c2nc(-c3ccncc3)no2)cc1.CCOc1ccc(-c2nc(-c3ccncc3)no2)c(O)c1.CCn1nc(C)cc1-c1nc(-c2ccncc2)no1.COc1ccc(-c2nc(-c3ccncc3)no2)cc1OC1CCCC1.c1cc(-c2noc(-c3ccc(C4CCCCC4)cc3)n2)ccn1
InChIInChI=1S/C21H25N3O.C19H19N3O3.C19H19N3O.C19H21N3O.C15H13N3O3.C13H13N5O/c1-20(2,3)16-11-15(12-17(13-16)21(4,5)6)19-23-18(24-25-19)14-7-9-22-10-8-14;1-23-16-7-6-14(12-17(16)24-15-4-2-3-5-15)19-21-18(22-25-19)13-8-10-20-11-9-13;1-2-4-14(5-3-1)15-6-8-17(9-7-15)19-21-18(22-23-19)16-10-12-20-13-11-16;1-13(2)12-15-4-6-16(7-5-15)14(3)19-21-18(22-23-19)17-8-10-20-11-9-17;1-2-20-11-3-4-12(13(19)9-11)15-17-14(18-21-15)10-5-7-16-8-6-10;1-3-18-11(8-9(2)16-18)13-15-12(17-19-13)10-4-6-14-7-5-10/h7-13H,1-6H3;6-12,15H,2-5H2,1H3;6-14H,1-5H2;4-11,13-14H,12H2,1-3H3;3-9,19H,2H2,1H3;4-8H,3H2,1-2H3
InChIKeyFDYOGOCTEIJWFC-UHFFFAOYSA-N
XLogP24.08
TPSA376.60 Ų
H-Bond Donors1
H-Bond Acceptors30
Rotatable Bonds22
Heavy Atoms136
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001824.18
LogP ≤ 524.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1030

Analyze 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole?
The IUPAC name of 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole (CID 158003016) is 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole.
What is the SMILES notation for 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole?
The canonical SMILES for 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole is CC(C)(C)c1cc(-c2nc(-c3ccncc3)no2)cc(C(C)(C)C)c1.CC(C)Cc1ccc(C(C)c2nc(-c3ccncc3)no2)cc1.CCOc1ccc(-c2nc(-c3ccncc3)no2)c(O)c1.CCn1nc(C)cc1-c1nc(-c2ccncc2)no1.COc1ccc(-c2nc(-c3ccncc3)no2)cc1OC1CCCC1.c1cc(-c2noc(-c3ccc(C4CCCCC4)cc3)n2)ccn1.
What is the InChIKey of 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole?
The InChIKey is FDYOGOCTEIJWFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N3O.C19H19N3O3.C19H19N3O.C19H21N3O.C15H13N3O3.C13H13N5O/c1-20(2,3)16-11-15(12-17(13-16)21(4,5)6)19-23-18(24-25-19)14-7-9-22-10-8-14;1-23-16-7-6-14(12-17(16)24-15-4-2-3-5-15)19-21-18(22-25-19)13-8-10-20-11-9-13;1-2-4-14(5-3-1)15-6-8-17(9-7-15)19-21-18(22-23-19)16-10-12-20-13-11-16;1-13(2)12-15-4-6-16(7-5-15)14(3)19-21-18(22-23-19)17-8-10-20-11-9-17;1-2-20-11-3-4-12(13(19)9-11)15-17-14(18-21-15)10-5-7-16-8-6-10;1-3-18-11(8-9(2)16-18)13-15-12(17-19-13)10-4-6-14-7-5-10/h7-13H,1-6H3;6-12,15H,2-5H2,1H3;6-14H,1-5H2;4-11,13-14H,12H2,1-3H3;3-9,19H,2H2,1H3;4-8H,3H2,1-2H3.
What are the key properties of 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole?
5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole has a molecular weight of 1824.18 g/mol, XLogP of 24.08, 22 rotatable bonds, 1 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4-cyclohexylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3-cyclopentyloxy-4-methoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-(3,5-ditert-butylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-ethoxy-2-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)phenol;5-(2-ethyl-5-methylpyrazol-3-yl)-3-pyridin-4-yl-1,2,4-oxadiazole;5-[1-[4-(2-methylpropyl)phenyl]ethyl]-3-pyridin-4-yl-1,2,4-oxadiazole is sourced from PubChem (CID 158003016), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).